Subependymal giant cell astrocytoma
Other Names for this Disease
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
- ClinicalTrials.gov lists trials that are studying or have studied Subependymal giant cell astrocytoma. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
(Novartis Pharmaceuticals Corporation)
The FDA has approved this product to be used in this manner.
|Treatment of patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis who require therapeutic intervention but are not candidates for curative surgical resection|
|More Information about this product||
Drug Information Portal
Medline Plus Health Information